Medicine Man Technologies, Inc. acquires Sucellus, LLC for USD 37,190,000 (2023)

Deal facts

Buyer: Medicine Man Technologies, Inc.
Target: Sucellus, LLC
Deal value: USD 37,190,000
Announced: 7 June 2023
Status: Completed
Sector: Other
Country: United States
Consideration: cash, loan-note, shares, earn-out

Sources

SEC_EDGAR_8K

What we know

More M&A Tools

Explore the Toolkit

Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.

Access now

Deal timeline

1 update

1 Jun 2023CompletedClosed
Medicine Man Technologies, Inc. completes acquisition of Sucellus, LLC
Item 1.01. Entry into a Material Definitive Agreement.. On June 1, 2023, Medicine Man Technologies, Inc. (the “Company”) and the Company’s indirect wholly-owned subsidiary, Evergreen Holdco, LLC, a New Mexico limited liability company (the “Everest Purchaser”), entered into an Amendment to Asset Purchase Agreement (the “Amendment”) with Sucellus, LLC, a New Mexico limited liability company (“Selle
Source

OpinionExit Mode editorial

We see a clear signal in the completed acquisition of Sucellus, LLC by Medicine Man Technologies, Inc. for a total value of 37.19 million USD. Announced in June 2023, this strategic deal highlights how buyers are moving beyond simple cash purchases to construct complex capital structures. The consideration package blends cash, loan notes, shares, and an earn-out. This mix suggests the buyer sought to manage immediate cash outflow while aligning the seller's future incentives with long-term performance. For the SME founder reading this, the structure itself tells a story about risk allocation and valuation confidence.

The inclusion of an earn-out alongside loan notes and shares indicates that the parties could not agree on a single static price. Instead, they deferred part of the valuation to future results. This is a common commercial mechanism when market conditions or sector volatility create a gap between buyer and seller expectations. The use of loan notes further implies that the buyer preferred to retain cash within the business while still offering the seller a debt-like instrument that ranks ahead of equity. Such arrangements often require careful drafting of change-of-control covenants to ensure the seller's interests are protected if the buyer's capital position shifts post-close.

Regulatory context here remains straightforward as both entities operate within the US, yet the complexity of the consideration types demands rigorous legal oversight. The deal is already marked as completed, which confirms that all necessary regulatory clearances and shareholder approvals were secured without material obstruction. The sector classification as 'Other' suggests a niche or emerging market where traditional valuation multiples may not apply, making the earn-out a critical tool to bridge the valuation gap. We believe this approach offers a pragmatic path forward when pure cash deals are unfeasible due to liquidity constraints or market uncertainty.

Your immediate action this week is to audit your own exit readiness by mapping your expected valuation against three distinct scenarios: a cash-only offer, a mixed consideration deal with an earn-out, and a pure share swap. Do not wait for a buyer to propose the structure; instead, model how each component affects your net proceeds and tax liability under current rules. If you cannot articulate the value of your future earn-out milestones today, you will struggle to defend them during negotiations tomorrow.

Editorial opinion. Not financial or legal advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

More Other deals More 2023 deals More strategic acquisition deals More from Medicine Man Technologies, Inc.All M&A deals

Similar deals

Other Other M&A activity tracked by Exit Mode.

10 July 2026Firm intentionOther

Vision Renu Corporation to acquire SUIC Worldwide Holdings Ltd.

Vision Renu Corporation has agreed to acquire SUIC Worldwide Holdings Ltd. in a strategic acquisition announced on 10 July 2026. The transaction involves a US-based buye…

Buyer: Vision Renu Corporation
Target: SUIC Worldwide Holdings Ltd.
Deal value: Not disclosed
Deal type: strategic acquisition

Read deal Other deals strategic acquisition deals United States deals

3 July 2026CompletedOther

Honeywell International, Inc. to acquire Catalyst Technologies

Honeywell International, Inc. has agreed to acquire Catalyst Technologies in a strategic acquisition announced on 3 July 2026. The transaction involves a US-based buyer…

Buyer: Honeywell International, Inc.
Target: Catalyst Technologies
Deal value: Not disclosed
Deal type: strategic acquisition

Read deal Other deals strategic acquisition deals United Kingdom deals

1 July 2026CompletedOther

Dalpo Group UK Limited to acquire Premier Limpet Limited

Dalpo Group UK Limited has agreed to acquire Premier Limpet Limited in a strategic acquisition valued at £10.1 million. The transaction consideration comprises a mix of…

Buyer: Dalpo Group UK Limited
Target: Premier Limpet Limited
Deal value: GBP 10,100,000
Deal type: strategic acquisition

Read deal Other deals strategic acquisition deals United Kingdom deals

29 June 2026CompletedOther

Nu-Med Plus, Inc. to acquire Avid Gold Ltd

Nu-Med Plus, Inc. and Avid Gold Ltd entered the Exit Mode archive.

Buyer: Nu-Med Plus, Inc.
Target: Avid Gold Ltd
Deal value: Not disclosed
Deal type: strategic acquisition

Read deal Other deals strategic acquisition deals United Kingdom deals

29 June 2026Firm intentionOther

DERICHEBOURG ENVIRONNEMENT to acquire SCHOLZ GROUP

DERICHEBOURG ENVIRONNEMENT has agreed to acquire SCHOLZ GROUP in a strategic acquisition announced on 29 June 2026. The transaction involves the purchase of the German w…

Buyer: DERICHEBOURG ENVIRONNEMENT
Target: SCHOLZ GROUP
Deal value: Not disclosed
Deal type: strategic acquisition

Read deal Other deals strategic acquisition deals Announced deals

Buyer history